The facility was inaugurated by Shri. Arjunsinh Chauhan, Hon’able Minister for Rural Housing & Development
· The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.
· The implants and equipment help in treating soft tissue problems especially in the shoulders and knees including meniscal repairs, ACL reconstruction, ligament reconstruction and repair
Ahmedabad, 09 December 2021: Healthium Medtech Limited (“Company” or “Healthium Medtech”), a global medical devices company focused on surgical, post-surgical and chronic care, today announced the launch of its latest manufacturing facility in Ahmedabad. The facility owned by Uteshiya Medicare, is located at the Rohisa Industrial Estate, and has been licenced by Healthium Medtech to exclusively manufacture its wide range of Arthroscopy products marketed under the brand “Sironix”. The CDSCO certified facility is spread across 70,000 sq ft.
Healthium Medtech is India’s largest independent medical devices company and second-largest company overall, in the surgical consumables market , the largest non-captive surgical needles manufacturer globally, by volume and the third-largest company overall in the urology collection devices market in the U.K as of fiscal 2021 .As on 31st March, 2021, one in five surgeries conducted globally, uses a Healthium product.
Healthium Medtech currently operates across eight integrated and scaled manufacturing facilities, several of which have global accreditations and registrations including US FDA, CE, ISO and TGA .Of these, seven are located in India spread across Karnataka, Uttar Pradesh, Andhra Pradesh, Tamil Nadu, Maharashtra and now Gujarat, and one in China. Healthium was the 1st Class III medical device company in India to receive a US FDA registration for one of its facilities. The Ahmedabad facility was inaugurated by Shri. Arjunsinh Chauhan, Hon’able Minister for Rural Housing & Development.
Mr. Anish Bafna, Chief Executive Officer and Managing Director, Healthium Medtech said, “It is with great pleasure that we announce the launch of our 7th manufacturing facility in India, at Ahmedabad. It is our endeavour to create high quality precision- based products, made in India through integrated scaled manufacturing. Arthroscopy is one of the fastest growing orthopaedic procedures in India, accounting for 15-17% of the overall procedures. We have created a patented portfolio of arthroscopy products at Healthium and we are very happy to have found in Uteshiya Medicare, a partner that offers the right environment to boost the manufacturing of our arthroscopy portfolio, while ensuring seamless delivery. I am confident that our broad-based expertise and strategic collaboration with Uteshiya , will help us make an impact in the lives of many.”
Mr. Jignesh Uteshiya, Director Uteshiya Medicare, said, “We are excited to have partnered with Healthium Medtech and look forward to manufacturing their patented arthroscopy portfolio in a completely green facility built using recycled materials, with built-in energy efficient systems, rainwater harvesting and onsite renewable energy generation. We are also optimizing and customizing operations for maximum efficiency with stringent quality control processes in place. Our most important capital is the perfect synergy of a green environment, competent talent and the effective use of global know-how through practical application.”
Arthroscopy products are used to help treat various knee and shoulder conditions such as anterior cruciate ligament reconstruction, posterior cruciate ligament injuries and other ligament reconstruction and repair and meniscal repair.
As per Frost & Sullivan report, the Indian arthroscopy devices market was valued at US$ 18.9 million in 2020, and estimated to reach US$ 47.1 million by 2025, implying a CAGR (2021-2025) of 18.6%.
Arthroscopy accounts for 15-17% of total orthopaedic procedures carried out in India, and is one of the fastest growing orthopaedic procedures. The volume of arthroscopy procedures conducted, is likely to triple in the next 5-6 years. Key drivers for growth of procedures include a growing base of arthroscopy centres and practicing specialists.